Stock Track | Viatris Soars 5.27% in Pre-market on Q1 Earnings Beat Driven by China Strength

Stock Track05-07

Viatris Inc. (VTRS) shares surged 5.27% in pre-market trading on Thursday, following the release of the company's first-quarter financial results that significantly exceeded analyst expectations.

The pharmaceutical company reported adjusted earnings per share of $0.59 for Q1 2026, beating the consensus estimate of $0.50. Revenue rose 8% year-over-year to $3.52 billion, also surpassing the expected $3.36 billion. The strong performance was primarily driven by exceptional growth in the Greater China region, where revenue increased by 22%, and robust sales of branded medicines including Lipitor and Norvasc.

Viatris also reaffirmed its full-year 2026 guidance, projecting adjusted EPS in the range of $2.33 to $2.47 on revenue of $14.45 billion to $14.95 billion, which aligns with market expectations. The company's return to profitability, with net earnings of $176.4 million compared to a loss a year earlier, further bolstered investor confidence ahead of the regular trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1175695100?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 22:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175695100","market":"sg","top_or_hot":-1,"title":"Stock Track | Viatris Soars 5.27% in Pre-market on Q1 Earnings Beat Driven by China Strength","media":"Stock Track","content":"<p>Viatris Inc. (VTRS) shares surged 5.27% in pre-market trading on Thursday, following the release of the company's first-quarter financial results that significantly exceeded analyst expectations.</p><p>The pharmaceutical company reported adjusted earnings per share of $0.59 for Q1 2026, beating the consensus estimate of $0.50. Revenue rose 8% year-over-year to $3.52 billion, also surpassing the expected $3.36 billion. The strong performance was primarily driven by exceptional growth in the Greater China region, where revenue increased by 22%, and robust sales of branded medicines including Lipitor and Norvasc.</p><p>Viatris also reaffirmed its full-year 2026 guidance, projecting adjusted EPS in the range of $2.33 to $2.47 on revenue of $14.45 billion to $14.95 billion, which aligns with market expectations. The company's return to profitability, with net earnings of $176.4 million compared to a loss a year earlier, further bolstered investor confidence ahead of the regular trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Viatris Soars 5.27% in Pre-market on Q1 Earnings Beat Driven by China Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Viatris Soars 5.27% in Pre-market on Q1 Earnings Beat Driven by China Strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-07 22:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Viatris Inc. (VTRS) shares surged 5.27% in pre-market trading on Thursday, following the release of the company's first-quarter financial results that significantly exceeded analyst expectations.</p><p>The pharmaceutical company reported adjusted earnings per share of $0.59 for Q1 2026, beating the consensus estimate of $0.50. Revenue rose 8% year-over-year to $3.52 billion, also surpassing the expected $3.36 billion. The strong performance was primarily driven by exceptional growth in the Greater China region, where revenue increased by 22%, and robust sales of branded medicines including Lipitor and Norvasc.</p><p>Viatris also reaffirmed its full-year 2026 guidance, projecting adjusted EPS in the range of $2.33 to $2.47 on revenue of $14.45 billion to $14.95 billion, which aligns with market expectations. The company's return to profitability, with net earnings of $176.4 million compared to a loss a year earlier, further bolstered investor confidence ahead of the regular trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VTRS","symbol_name":"Viatris Inc.","start_time":0,"source_url":"","article_id":"1175695100","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175695100","pubTimestamp":1778164162,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Viatris Inc. (VTRS) shares surged 5.27% in pre-market trading on Thursday, following the release of the company's first-quarter financial results that significantly exceeded analyst expectations.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VTRS":"Viatris Inc."},"translate_title":"个股追踪|Viatris盘前飙升5.27%，Q1盈利超预期受中国实力推动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTRS":1},"content_text":"Viatris Inc. (VTRS) shares surged 5.27% in pre-market trading on Thursday, following the release of the company's first-quarter financial results that significantly exceeded analyst expectations.The pharmaceutical company reported adjusted earnings per share of $0.59 for Q1 2026, beating the consensus estimate of $0.50. Revenue rose 8% year-over-year to $3.52 billion, also surpassing the expected $3.36 billion. The strong performance was primarily driven by exceptional growth in the Greater China region, where revenue increased by 22%, and robust sales of branded medicines including Lipitor and Norvasc.Viatris also reaffirmed its full-year 2026 guidance, projecting adjusted EPS in the range of $2.33 to $2.47 on revenue of $14.45 billion to $14.95 billion, which aligns with market expectations. The company's return to profitability, with net earnings of $176.4 million compared to a loss a year earlier, further bolstered investor confidence ahead of the regular trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1175695100","isCrawlerRequest":true}